Trump Admin Delays Penalties For Drug Price Overcharges

By John Kennedy (October 3, 2017, 4:59 PM EDT) -- The Trump administration has delayed the implementation of a rule that would penalize drug manufacturers for overcharging certain health care providers, such as those that treat children and cancer patients, saying the extra time is necessary to allow drugmakers to comply and to let the agency sort out questions and objections regarding the rule....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!